Is knowledge translation adequate? A quality assurance study of staging investigations in early stage breast cancer patients Dolly HanSophie HogeveenChristine E. Simmons Review 25 September 2011 Pages: 1 - 7
Bloody nipple discharge is a predictor of breast cancer risk: a meta-analysis Ling ChenWen-Bin ZhouShui Wang Review 27 September 2011 Pages: 9 - 14
Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology Felipe C. GeyerDario de BiaseGiovanni Tallini Preclinical study 21 April 2011 Pages: 15 - 28
Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes Sandrine BoyaultYouenn DrouetQing Wang Preclinical study 22 April 2011 Pages: 29 - 39
Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains Anja BrügmannMikkel EldMogens Vyberg Preclinical study 22 April 2011 Pages: 41 - 49
COX2 overexpression is a prognostic marker for Stage III breast cancer Hee Sung KimHyeong-Gon MoonDong-Young Noh Preclinical study 28 April 2011 Pages: 51 - 59
Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth Angelo J. CasaAdam S. PotterAdrian V. Lee Preclinical study 04 May 2011 Pages: 61 - 73
Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs I. K. GuttillaK. N. PhoenixB. A. White Preclinical study 07 May 2011 Pages: 75 - 85
Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing Kim De LeeneerIlse CoeneKathleen Claes Preclinical study 07 May 2011 Pages: 87 - 95
Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis Sivapriya RamamoorthyRozina TufailZafar Nawaz Preclinical study 08 May 2011 Pages: 97 - 108
ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells Katherine M. AirdJennifer L. AllensworthGayathri R. Devi Preclinical study 11 May 2011 Pages: 109 - 119
The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer Malgorzata BanysNatalia KrawczykRalf Rothmund Preclinical study 12 May 2011 Pages: 121 - 129
Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes Rinat YerushalmiKaren A. GelmonHagen Kennecke Preclinical Study 15 May 2011 Pages: 131 - 142
Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification Luke Yong-Zheng ChongPoh Yian CheokPuay Hoon Tan Preclinical study 15 May 2011 Pages: 143 - 151
Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway Xin-long YanChun-jiang FuXue-tao Pei Preclinical Study 17 May 2011 Pages: 153 - 164
Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay Noriaki YamamotoTakahiro NakayamaShinzaburo Noguchi Preclinical Study 19 May 2011 Pages: 165 - 173
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles Abena S. AgyemanRaghothama ChaerkadyThomas W. Kensler Preclinical Study 20 May 2011 Pages: 175 - 187
Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer Musaffe TunaMarcel SmidJohn A. Foekens Preclinical Study 21 May 2011 Pages: 189 - 196
Twenty-five year results of the national cancer institute randomized breast conservation trial Nicole L. SimoneTu DanKevin Camphausen Clinical Trial 24 November 2011 Pages: 197 - 203
Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting Jennifer A. LigibelJeffrey MeyerhardtCharles Shapiro Clinical trial 24 November 2011 Pages: 205 - 213
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer A. J. MonteroC. M. Diaz-MonteroS. Glück Clinical trial 03 December 2011 Pages: 215 - 223
TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients Pernille Braemer HertelDongsheng TuTorsten O. Nielsen Clinical trial 09 December 2011 Pages: 225 - 234
Incremental increase in VEGFR1+ hematopoietic progenitor cells and VEGFR2+ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients Sarika JainMaureen M. WardLinda T. Vahdat Clinical trial 09 December 2011 Pages: 235 - 242
Folate intake and breast cancer mortality in a cohort of Swedish women Holly R. HarrisLeif BergkvistAlicja Wolk Epidemiology 26 October 2011 Pages: 243 - 250
Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features Juliana S. Festa-VasconcellosDiogo N. PirandaRosane Vianna-Jorge Epidemiology 30 October 2011 Pages: 251 - 258
The association between mammographic density measures and aspirin or other NSAID use Jennifer StoneLisa WillenbergJohn Hopper Epidemiology 30 October 2011 Pages: 259 - 266
Epstein–Barr virus is seldom found in mammary epithelium of breast cancer tissue using in situ molecular methods Kimberly BaltzellGertrude C. BuehringJennette D. Sison Epidemiology 01 November 2011 Pages: 267 - 274
Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials Carolyn J. CrandallAaron K. AragakiRowan T. Chlebowski Epidemiology 01 November 2011 Pages: 275 - 285
Women’s features and inter-/intra-rater agreement on mammographic density assessment in full-field digital mammograms (DDM-SPAIN) Beatriz Pérez-GómezFranciso RuizDolores Salas Epidemiology 01 November 2011 Pages: 287 - 295
Hormone therapy use and mammographic density in postmenopausal Norwegian women Elisabeth CoutoSamera Azeem QureshiGiske Ursin Epidemiology 04 November 2011 Pages: 297 - 305
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer Ana BlancoMiguel de la HoyaAna Vega Epidemiology 04 November 2011 Pages: 307 - 315
Prognostic role of CA15.3 in 7942 patients with operable breast cancer M. T. SandriM. SalvaticiM. Colleoni Epidemiology 09 November 2011 Pages: 317 - 326
Correlation of white female breast cancer incidence trends with nitrogen dioxide emission levels and motor vehicle density patterns Fan ChenWilliam F. Bina Epidemiology 11 November 2011 Pages: 327 - 333
Somatic mutations in the BRCA1 gene in Chinese women with sporadic breast cancer Min ZhangYe XuYuntao Xie Brief Report 25 November 2011 Pages: 335 - 340
Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry Yonglan ZhengTemidayo O. OgundiranDezheng Huo Brief Report 29 November 2011 Pages: 341 - 345
Evaluating breast cancer risk projections for Hispanic women Matthew P. BanegasMitchell H. GailHormuzd A. Katki Brief Report 07 December 2011 Pages: 347 - 353
